We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Cellar Rats, led by Founder and CEO Matt, aims to disrupt the wine industry by changing the way people discover, buy, and enjoy wine. With a background in successfully transforming consumer brands, they're determined to revolutionize the UK's £17 billion wine market, which currently faces challenges due to a lack of consumer wine knowledge. Starting with a subscription service and extending to shake up traditional wine retail, Cellar Rats is poised to reshape the wine industry from the ground up.
days to go: Expired investment: £282,164
Mami Wata (MW) is a purpose-led, premium African surf lifestyle brand on a mission to redefine the global surf market. MW asserts that it has collaborated with global luxury brand, Moncler, and partnered with renowned stockists including Mr Porter and Huckberry. It aims to be a contender in the $9 billion global surfing market. It has also shipped 1200+ copies of its AFROSURF art book to 39 countries along with funding a surf therapy clubhouse in Harper, Liberia. MW has sold products to 7,500+ customers generating more than £400,000 in revenue to date. The company has featured in global media entities such as CNN, GQ, Wallpaper, Monocle, and HypeBeast. MW will use the investment for its international launch in the USA.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,145,799
VitaLife founded Love Health Hate Waste out of their frustration for throwing away unsold/ expired stock. Love Health Hate Waste aim to reduce food waste and make healthy food and drink accessible to everyone. 
days to go: Expired investment: £6,910
The Dip Society are a fresh food brand, specialising in dips made from 100% natural ingredients which are gluten and dairy free. The dips and pate are made from no more than 10 ingredients in each pot and are great for sharing with friends or for enjoying on the go. The dips are currently stocked in selected Ocado, Selfridges & co, Booths, and Co op stores.
days to go: Expired investment: £315,420
Metal matrix composite components and materials, primarily comprised of aluminium for use in the engineering and manufacturing industries. Alvant specialise in designing, developing and producing the composite for well-known clients such as Ford and Safran. In the last financial year, Alvant achieved a turnover of almost £617k and has invested more than £10m towards manufacturing and testing their own product. Alvant is now raising funds to distribute their components to a wider market and expand the number of commercial applications that would benefit from their materials.
days to go: Expired investment: £2,105,001
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph